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LETTERS
Has the ﬁrst-line management
of paediatric OCD improved
following the introduction of
NICE guidelines?
INTRODUCTION
Obsessive–compulsive disorder (OCD) is a
distressing and impairing condition that
affects between 0.25% and 4% of children
and adolescents.1 In 2005, the National
Institute of Health and Care Excellence
(NICE) introduced guidelines for the man-
agement of paediatric OCD in the UK.2
Based on robust evidence, NICE recom-
mended cognitive behavioural therapy
(CBT) and selective serotonin reuptake
inhibitors (SSRIs) as ﬁrst-line psychological
and pharmacological treatments. However,
the extent to which patients are able to
access these evidence-based interventions
in routine clinical practice remains unclear.
To assess the impact of these guidelines,
we conducted an audit of the previous
treatment received by children with OCD
referred to the National and Specialist
Paediatric (N&S) OCD clinic at the
Maudsley Hospital, London. We hypothe-
sised that publication of NICE guidelines,
in 2005, would increase the use of SSRIs
and CBT in this group of patients.
METHODS
We compared referrals received from
January 2000 to January 2002 (T1 cohort,
n=79) with those from January 2009 to
January 2011 (T2 cohort, n=143). All
data were collected as part of the routine
standardised assessment carried out in the
N&S OCD clinic. Table 1 shows the base-
line demographic/clinical data collected
for each cohort. Treatment data were cate-
gorised into whether patients had ever pre-
viously received CBT for OCD, an SSRI
medication or a non-CBT-based psycho-
therapy (eg, family therapy, counselling,
psychodynamic therapy) or whether they
had received either NICE-recommended
treatment (SSRI or CBT).
RESULTS
Table 1 details our results. Comparing the
two groups, the T2 cohort (after NICE
guideline publication) were signiﬁcantly
older (mean increase of 8.3 months, t(220)
=−2.16, p=0.03) and reported more severe
OCD symptoms (mean Children’s
Yale-Brown Obsessive Compulsive Scale
(CY-BOCS) score increase of 4.58 points, t
(220)=−6.03, p<0.001). There were no
signiﬁcant differences in gender, age at
onset of OCD symptoms, or referral source.
Contrary to our hypothesis, when com-
paring patients in the T2 cohort with those
in the T1 cohort, we found a signiﬁcant
22.3% decrease in the proportion who
had received either NICE-recommended
treatments (SSRI or CBT) (χ2 (1, n=222)
=10.18, p=0.001), with over half having
not received either treatment. There was a
signiﬁcant 23.0% decrease in the propor-
tion who had received an SSRI (χ2
(1, n=222)=23.87, p<0.001) and no
signiﬁcant increase in patients receiving
CBT (χ2 (1, n=222)=0.66, p=0.418). We
also found a signiﬁcant 13.1% increase in
the proportion of patients receiving
non-CBT psychotherapy (χ2 (1, n=222)
=5.38, p=0.019).
DISCUSSION
Despite the publication of NICE guidelines
in 2005, we found a striking decrease in
SSRI use, no increase in the use of CBT,
and an increase in non-CBT-based psy-
chotherapies between our two cohorts.
Shortage of CBT therapists in child ser-
vices and concerns around the safety of
SSRIs in this population may explain some
of our ﬁndings.3 4 Further work is urgently
needed to identify the barriers preventing
young people with OCD from accessing
evidence-based treatments.
Akshay Nair,1 Yim Lun Wong,2 Faye Barrow,3
Isobel Heyman,4,5 Bruce Clark,1
Georgina Krebs1,6
1National Obsessive Compulsive Disorder Service,
Michael Rutter Centre, Maudsley Hospital, London, UK
2Coventry and Warwickshire NHS Partnership Trust,
Coventry, UK
3The Oxford Institute of Clinical Psychology Training,
University of Oxford, Oxford, UK
4Psychological Medicine Team, Department of Child
and Adolescent Mental Health, Great Ormond Street
Hospital for Children, London, UK
5Institute of Child Health, University College London,
London, UK
6Social, Genetic and Developmental Psychiatry Centre,
Institute of Psychiatry, Psychology and Neuroscience,
King’s College London, London, UK
Correspondence to Dr Akshay Nair, National
Obsessive Compulsive Disorder Service, Michael Rutter
Centre, Maudsley Hospital, London SE5 8AZ, UK;
akshay.nair@kcl.ac.uk
Contributors AN collected data in the T2 cohort,
contributed to design of the audit, analysed data and
wrote manuscript drafts. YLW collected data in the T1
cohort. FB collated data at the time of assessment and
maintained the database. IH designed the data
collection and reviewed the manuscript. BC contributed
to the design of the audit and reviewed the
manuscript. GK contributed to the design of the audit,
helped with data analysis and reviewed the manuscript.
Funding AN and GK receive salary support from the
National Institute for Health Research (NIHR) Mental
Health Biomedical Research Centre at South London
and Maudsley NHS Foundation Trust and King’s College
London
Competing interests None.
Provenance and peer review Not commissioned;
internally peer reviewed.
Table 1 Characteristics of each cohort
T1: 2000–2002 cohort
(n=79)
T2: 2009–2011 cohort
(n=143)
Clinical characteristics
Female, % 41.8 46.9
Age at assessment, mean
(95% CI)
13 years 10 months (9 years 5 months to
17 years 3 months)
14 years 7 months* (11 years to
17 years 8 months)
Age at onset, mean
(95% CI)
10 years 1 months (5 years to 14 years) 10 years 6 months (11 years to
17 years 4 months)
Baseline CY-BOCS, mean
(95% CI)
22 (12 to 32) 26 (18 to 35)***
Referral source, %
Child Psychiatry Services 69.6 73.4
General practitioner 27.8 23.8
Paediatricians 1.3 1.4
Other 1.3 1.4
Previous treatments, %
CBT or SSRI 67.1 44.8**
CBT 31.6 37.1
SSRI 58.2 25.2***
Non-CBT psychotherapy 11.4 24.5*
Children’s Yale-Brown Obsessive Compulsive Scale (CY-BOCS) reliably measures OCD symptoms severity.
*p<0.05, **p<0.01, ***p<0.001, significant difference between cohorts.
CBT, cognitive behavioural therapy; OCD, obsessive–compulsive disorder; SSRI, selective serotonin reuptake inhibitor.
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PAWS for thought
Paediatric Advanced Warning Scores
(PAWS), or Paediatric Early Warning Scores
(PEWS), are scales that are based on clinical
observations intended to predict deterior-
ation. There are a variety of tools in use in
the UK. Although standards for such tools
have been suggested,1 2 a systematic review
has made it clear that scores were lacking in
validity and reliability.3 The use of such
tools has increased over time and broa-
dened to include sub-specialty locations
with a higher risk of acute deterioration.4
We undertook a case-note review of the
prevalence of raised PAWS (≥3; the trigger
for medical review) and clinician’s
responses to these in patients under the
care of paediatric haematology and oncol-
ogy in the Leeds Children’s Hospital.
A total of 140 patient observation points
were randomly selected, stratiﬁed by time
period and date. PAWS and clinical details
were recorded for each observation point,
48 h before and after this point.
Data were available on 103 of the
observation points, with 37 missing
through difﬁculties obtaining the PAWS
charts. Twenty-eight of 103 (27.2%) had
a PAWS ≥3. In the 48 h before and after
the time point, 63.1% and 61.8% of inpa-
tients had a PAWS ≥3, respectively.
Nine of the patients with raised PAWS
had a nursing review documented, with a
medical review requested in two patients.
Another patient received a medical review
without documented nursing review. Four
patients with a low PAWS received a
medical review due to other clinical
concerns.
Of the 28 patients with PAWS ≥3 at the
index time point, four had an adverse event
in the preceding 48 h and ﬁve had an
adverse event in the following 48 h (includ-
ing one patient who had an adverse event
in both time frames). Eleven of the 19
recorded adverse events occurred in
patients with PAWS <3. One adverse event
necessitated pediatric intensive care unit
admission, while the other events included
new bacteraemia, administration of ﬂuid
boluses, acute renal impairment, acute right
hemiplegia and medication error (see
ﬁgure 1).
We conclude that a raised PAWS does not
necessarily indicate signiﬁcant deterior-
ation, noting that the majority of adverse
events occurred in patients without raised
PAWS. In this population, the sensitivity
and speciﬁcity of a PAWS ≥3 was poor (sen-
sitivity 0.56 (CI 0.21 to 0.86) and speciﬁ-
city 0.76 (CI 0.66 to 0.84)), to detect a
future adverse event. We acknowledge that
our review was limited by reference only to
documented scores and reviews, and that
the effects of the reviews apparently trig-
gered by PAWS may have prevented other
adverse events. Further consideration needs
to be taken to identify the appropriate early
detection systems (both the scores and
interventional advice) for patients under
the care of paediatric haematology and
oncology, as performing the recommended
interventions is not feasible or efﬁcient with
current resources. Work is ongoing within
Leeds Children’s Hospital to develop such
a system—further evaluation will be per-
formed following its implementation.
Other subspecialties might also consider
how early warning score systems could be
adjusted for their populations.
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Figure 1 Interaction between Paediatric
Advanced Warning Scores (PAWS) and adverse
events (AEs).
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